FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Market Closed - Deutsche Boerse AG 01:20:30 29/06/2024 am IST | ||
| 17.27 EUR | -13.52% |
|
| Current month | -43.80% | ||
| 1 month | -37.36% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 17.27 | -13.52% |
| 27/24/27 | 19.97 | -9.64% |
| 26/24/26 | 22.1 | -2.99% |
| 25/24/25 | 22.78 | -13.91% |
| 24/24/24 | 26.46 | +9.98% |
Delayed Quote Deutsche Boerse AG
Last update June 29, 2024 at 01:20 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PC12QD |
| ISIN | DE000PC12QD4 |
| Date issued | 07/11/2023 |
| Strike | 137.3 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 148 € |
|---|---|
| Lowest since issue | 11.64 € |
| Spread | 0.72 € |
| Spread % | 3.67% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
136.9
USD
Average target price
147
USD
Spread / Average Target
+7.39%
- Stock Market
- Certificates
- Certificat
